Effect of Adenosine A2 receptor activation on the mitochondrial death pathway
腺苷A2受体激活对线粒体死亡途径的影响
基本信息
- 批准号:7842054
- 负责人:
- 金额:$ 22.38万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2009
- 资助国家:美国
- 起止时间:2009-07-15 至 2011-06-30
- 项目状态:已结题
- 来源:
- 关键词:1-Phosphatidylinositol 3-KinaseAccountingAcute myocardial infarctionAdenosineAdenosine A2 ReceptorsAdenosine-5&apos-(N-ethylcarboxamide)AgonistAgreementApoptosisApoptoticAttenuatedBiologicalCardiac MyocytesCellular biologyCessation of lifeChelating AgentsCyclic AMP-Dependent Protein KinasesCyclic GMPDataGene TargetingGenerationsGenesGeneticGlycogen Synthase Kinase 3Glycogen Synthase KinasesGoalsHeartHeart BlockHeat-Shock Proteins 90InfarctionIschemiaIschemic PreconditioningKnock-outKnockout MiceLeadMeasuresMediatingMembrane PotentialsMitochondriaMolecular BiologyMyocardial IschemiaMyocardiumNecrosisNitric OxideOxidantsPathway interactionsPatientsPharmacologyPhosphorylationPhysiologyPilot ProjectsPlayPreventionPreventiveProtein Tyrosine KinaseRattusReceptor ActivationReperfusion InjuryReperfusion TherapyReportingRoleSignal PathwaySignal TransductionTechniquesTestingWorkZincclinically significantdesignindexinginhibitor/antagonistinsightknockout genemitochondrial dysfunctionmitochondrial membranemitochondrial permeability transition poremyocardial infarct sizingnoveloverexpressionpreventprotective effectreceptor
项目摘要
DESCRIPTION (provided by applicant): A large number of recent studies have associated a mitochondrial death pathway at reperfusion with both necrosis and apoptosis. Preventing the mitochondrial death pathway, therefore, is a prerequisite for successful cardioprotection at reperfusion. Although adenosine A2 receptor activation at reperfusion has been proposed to protect the heart, its mechanisms are still not clear. The objective of this proposal is to determine the effects of A2 receptor activation on the mitochondrial death pathway and to elucidate the signaling mechanisms underling the effects of A2 receptor activation. We hypothesize that stimulation of A2 receptor activation by NECA at reperfusion interdicts the mitochondrial death pathway through a signal cascade involving eNOS, NO, PKG, zinc, and GSK-3. We will test these hypotheses by using diverse techniques of cell biology, molecular biology, physiology, pharmacology, and gene targeting. Aim 1 will determine the effects of A2 receptor activation at reperfusion on the mitochondrial death pathway by measuring mitochondrial function, infarct size, and indexes of apoptosis. Aim 2 will determine the mechanisms by which A2 receptor activation produces NO by defining the roles of PKA, tyrosine kinase, and HSP90 in activation of eNOS. Aim 3 will determine the role of PKG in the protective action of A2 receptor activation. We will define the role of PKG by overexpressing or knocking out the PKG gene. Aim 4 will ascertain the downstream targets of PKG activation that lead to the preventive effects of A2 receptor activation on the mitochondrial death pathway. Towards this goal we will characterize the roles of intracellular free zinc, mitochondrial KATP channels, and GSK-3. The successful execution of this proposal should produce important new insights into the signaling mechanisms underlying the protective effects of A2 receptor activation at reperfusion against ischemia/reperfusion injury, and have great clinical significance for treating patients with acute myocardial infarction.
描述(由申请人提供):大量最近的研究将再灌注时的线粒体死亡途径与坏死和凋亡均相关。因此,防止线粒体死亡途径是在再灌注时成功进行心脏保护的先决条件。尽管已经提出了在再灌注时腺苷A2受体激活以保护心脏,但其机制仍然尚不清楚。该建议的目的是确定A2受体激活对线粒体死亡途径的影响,并阐明A2受体激活作用的信号机制。我们假设NECA在再灌注中刺激A2受体激活的刺激通过涉及eNOS,NO,PKG,锌和GSK-3的信号级联反应的线粒体死亡途径。我们将通过使用细胞生物学,分子生物学,生理学,药理学和基因靶向的各种技术来检验这些假设。 AIM 1将通过测量线粒体功能,梗塞大小和凋亡指数来确定A2受体激活对再灌注对线粒体死亡途径的影响。 AIM 2将通过定义PKA,酪氨酸激酶和HSP90在ENOS激活中的作用来确定A2受体激活产生NO的机制。 AIM 3将确定PKG在A2受体激活的保护作用中的作用。我们将通过过表达或淘汰PKG基因来定义PKG的作用。 AIM 4将确定PKG激活的下游靶标,从而导致A2受体激活对线粒体死亡途径的预防作用。为了实现这一目标,我们将表征细胞内游离锌,线粒体KATP通道和GSK-3的作用。该提案的成功执行应产生重要的新见解,以对反对缺血/再灌注损伤时A2受体激活的保护作用的信号传导机制产生重要的作用,并且对于治疗急性心肌梗死患者的临床意义很高。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
ZHELONG XU其他文献
ZHELONG XU的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('ZHELONG XU', 18)}}的其他基金
Effect of Adenosine A2 receptor activation on the mitochondrial death pathway
腺苷A2受体激活对线粒体死亡途径的影响
- 批准号:
7898949 - 财政年份:2006
- 资助金额:
$ 22.38万 - 项目类别:
Adenosine A2 receptor activation--mitochondrial death
腺苷A2受体激活——线粒体死亡
- 批准号:
7139769 - 财政年份:2006
- 资助金额:
$ 22.38万 - 项目类别:
Effect of Adenosine A2 receptor activation on the mitochondrial death pathway
腺苷A2受体激活对线粒体死亡途径的影响
- 批准号:
7261330 - 财政年份:2006
- 资助金额:
$ 22.38万 - 项目类别:
Effect of Adenosine A2 receptor activation on the mitochondrial death pathway
腺苷A2受体激活对线粒体死亡途径的影响
- 批准号:
7651410 - 财政年份:2006
- 资助金额:
$ 22.38万 - 项目类别:
Effect of Adenosine A2 receptor activation on the mitochondrial death pathway
腺苷A2受体激活对线粒体死亡途径的影响
- 批准号:
7474077 - 财政年份:2006
- 资助金额:
$ 22.38万 - 项目类别:
相似国自然基金
签字注册会计师动态配置问题研究:基于临阵换师视角
- 批准号:72362023
- 批准年份:2023
- 资助金额:28 万元
- 项目类别:地区科学基金项目
全生命周期视域的会计师事务所分所一体化治理与审计风险控制研究
- 批准号:72372064
- 批准年份:2023
- 资助金额:40 万元
- 项目类别:面上项目
会计师事务所数字化能力构建:动机、经济后果及作用机制
- 批准号:72372028
- 批准年份:2023
- 资助金额:42.00 万元
- 项目类别:面上项目
会计师事务所薪酬激励机制:理论框架、激励效应检验与优化重构
- 批准号:72362001
- 批准年份:2023
- 资助金额:28.00 万元
- 项目类别:地区科学基金项目
环境治理目标下的公司财务、会计和审计行为研究
- 批准号:72332002
- 批准年份:2023
- 资助金额:165.00 万元
- 项目类别:重点项目
相似海外基金
Elucidating Non-Routine Events Arising from Interhospital Transfers
阐明院间转移引起的非常规事件
- 批准号:
10749448 - 财政年份:2023
- 资助金额:
$ 22.38万 - 项目类别:
Leveraging a novel health records platform to predict the development of cardiovascular disease following kidney transplantation
利用新型健康记录平台预测肾移植后心血管疾病的发展
- 批准号:
10679322 - 财政年份:2023
- 资助金额:
$ 22.38万 - 项目类别:
Identifying the Causes of the Stagnation in National U.S. Cardiovascular Disease Mortality
查明美国全国心血管疾病死亡率停滞不前的原因
- 批准号:
10585800 - 财政年份:2023
- 资助金额:
$ 22.38万 - 项目类别:
Role of small RNAs in ischemic tissue repair
小RNA在缺血组织修复中的作用
- 批准号:
10736743 - 财政年份:2023
- 资助金额:
$ 22.38万 - 项目类别:
Implementation of a Stroke Protocol for Emergency Evaluation and Disposition (HI-SPEED)
实施中风紧急评估和处置方案 (HI-SPEED)
- 批准号:
10647353 - 财政年份:2023
- 资助金额:
$ 22.38万 - 项目类别: